{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:50:12Z","timestamp":1791132612283,"version":"4.1.0"},"reference-count":9,"publisher":"Hindawi Limited","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1050,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1742-1241.2012.03010.x","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T10:57:53Z","timestamp":1350385073000},"page":"1052-1055","source":"Crossref","is-referenced-by-count":66,"title":["A 5-year retrospective analysis of 5\u03b1-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride"],"prefix":"10.1155","volume":"66","author":[{"given":"S. A.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Te","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1464-410X.2011.10195.x","article-title":"Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)","volume":"108","author":"Nickel","year":"2011","journal-title":"Br J Urol Int"},{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5\u03b1-reductase inhibitor","volume":"89","author":"Clark","year":"2004","journal-title":"J Clin Endocrin Metab"},{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","article-title":"The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia","volume":"338","author":"McConnell","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","article-title":"Efficacy and safety of dual inhibitor of 5-alpha reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","volume":"60","author":"Roehrborn","year":"2002","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.juro.2007.09.084","article-title":"The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study","volume":"179","author":"Roehrborn","year":"2008","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.pcan.4500931","article-title":"The effect of dutasteride on intraprostaticdihydrotestosterone concentrations in men with benign prostatic hyperplasia","volume":"10","author":"Wurzel","year":"2007","journal-title":"Prostate Cancer & Prost Dis"},{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/jcem-71-6-1552","article-title":"Effect of finasteride, a 5\u03b1 -reductase inhibitor on prostate tissue androgens and prostate-specific antigen","volume":"71","author":"Geller","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2012.03010.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/jc.74.3.505","article-title":"Finasteride, an inhibitor of 5\u03b1-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia","volume":"74","author":"McConnell","year":"1992","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1111\/ijcp.12132","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,2,15]],"date-time":"2013-02-15T00:00:00Z","timestamp":1360886400000}}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2012.03010.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2012.03010.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:03:37Z","timestamp":1643349817000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2012.03010.x"}},"subtitle":["A 5-year retrospective analysis of 5\u03b1-reductase inhibitors in men"],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2012.03010.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,16]]}}}